Overcoming limitations in the detection of mixed chimerism
This paper by Dr. Dan Hauzenberger, Medical Director of the Section for Transplantation Immunology at Karolinska University Hospital, Sweden, highlights the importance of chimerism as a diagnostic tool for clinicians treating transplanted patients. Furthermore, the evolution of novel diagnostic tools for early detection of mixed chimerism is discussed. The recent development of NGS technology offers the possibility to analyze mixed chimerism with both sensitivity, as well as accurate and precise determination.
- Importance of detecting mixed chimerism.
- Methods for detection of mixed chimerism.
- Recent development of NGS technology and its possibilities.
Get access to the paper by filling out the form below
Overcoming limitations in the detection of mixed chimerism
This paper by Dr. Dan Hauzenberger, Medical Director of the Section for Transplantation Immunology at Karolinska University Hospital, Sweden, highlights the importance of chimerism as a diagnostic tool for clinicians treating transplanted patients. Furthermore, the evolution of novel diagnostic tools for early detection of mixed chimerism is discussed. The recent development of NGS technology offers the possibility to analyze mixed chimerism with both sensitivity, as well as accurate and precise determination.
- Importance of detecting mixed chimerism.
- Methods for detection of mixed chimerism.
- Recent development of NGS technology and its possibilities.
Related content
View allDevyser Diagnostics AB publishes quarterly report for the period April to June 2024
“Devyser continued to report high sales growth in the second quarter. Organic growth compared with...
Read More
Devyser wins tender in Italy for its cystic fibrosis NGS test worth up to 5.9 million SEK
Read More
Devyser wins tender in Sweden for Thalassemia NGS testing worth up to 8.4 million SEK
Read More